Wallace Y Langdon

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Regulatory T Cells

Top Venues

Journal of immunology (Baltimore, Md. : 1950)

Science signaling

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Huang, Yilei Ma, Hui Guo, Na Tang, Song Ouyang, Patrick K Nuro-Gyina, Lijian Tao, Yusen Liu, Matthew C O'Brien, Wallace Y Langdon, Jian Zhang
Akt-2 Is a Potential Therapeutic Target for Disseminated Candidiasis. Journal of immunology (Baltimore, Md. : 1950) 209 (5) (2022)
Juan Tang, Yizhi Xiao, Guoxin Lin, Hui Guo, Han-Xiang Deng, Sha Tu, Wallace Y Langdon, Huixiang Yang, Lijian Tao, Yalan Li, R Marshall Pope, Neetu Gupta, Jian Zhang
Tyrosine phosphorylation of NLRP3 by the Src family kinase Lyn suppresses the activity of the NLRP3 inflammasome. Science signaling 14 (706) (2021)
Song Ouyang, Qiuming Zeng, Na Tang, Hui Guo, Rong Tang, Weifan Yin, Aimin Wang, Hongyu Tang, Jiru Zhou, Hong Xie, Wallace Y Langdon, Huan Yang, Jian Zhang
Akt-1 and Akt-2 Differentially Regulate the Development of Experimental Autoimmune Encephalomyelitis by Controlling Proliferation of Thymus-Derived Regulatory T Cells. Journal of immunology (Baltimore, Md. : 1950) 202 (5) (2019)
Samuel J Taylor, Johanna M Duyvestyn, Samantha A Dagger, Emma J Dishington, Catherine A Rinaldi, Oliver M Dovey, George S Vassiliou, Carolyn S Grove, Wallace Y Langdon
Preventing chemotherapy-induced myelosuppression by repurposing the FLT3 inhibitor quizartinib. Science translational medicine 9 (402) (2018)